Proteomic Profiling of Multiple Myeloma (MM) Cells Using iTRAQ and Label-Free Quantitative Proteomics for the Prediction of Complete or near Complete Response (CR/nCR) In Frontline Treatment with Lenalidomide, Bortezomib, and Dexamethasone

被引：1
|
作者：
Dytfeld, Dominik [1 ]
Kandarpa, Malathi [1 ]
Strahler, John R. [2 ]
Mellacheruvu, Dattatreya [3 ]
Subramani, Suchitra [1 ]
Kraftson, Stephanie J. [1 ]
Ngoka, Lambert [4 ]
Nesvizhskii, Alexey [3 ]
Sreekumar, Arun [4 ]
Richardson, Paul G. [5 ]
Jakubowiak, Andrzej J. [1 ]
机构：
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Med Coll Georgia, Augusta, GA 30912 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：271 / 272
页数：2
相关论文
共 2 条
  • [1] Superior Complete Response Rate (CR) and Progression-Free Survival (PFS) with Bortezomib-Thalidomide-Dexamethasone (VTD) Versus Thalidomide-Dexamethasone (TD) As Consolidation Therapy After Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)
    Cavo, Michele
    Pantani, Lucia
    Patriarca, Francesca
    Petrucci, Maria Teresa
    Galli, Monica
    Di Raimondo, Francesco
    Rossi, Giuseppe
    Palumbo, Antonio
    Tacchetti, Paola
    Offidani, Massimo
    Montefusco, Vittorio
    Narni, Franco
    Spadano, Tonino
    Cellini, Claudia
    Pescosta, Norbert
    Baldini, Luca
    Ledda, Antonio
    Di Toritto, Tommaso Caravita
    Pezzi, Annalisa
    Falcone, Antonietta
    Nozzoli, Chiara
    Zambello, Renato
    Masini, Luciano
    Gherlinzoni, Filippo
    Petti, Maria Concetta
    Derudas, Daniele
    Ballanti, Stelvio
    De Stefano, Valerio
    Baccarani, Michele
    BLOOD, 2011, 118 (21) : 816 - 816
  • [2] Multivariable Analyses of Prognostic Factors for Progression-Free Survival (PFS) and Complete Response (CR) with Lenalidomide, Bortezomib, and Dexamethasone (RVd) Alone Versus Rvd Plus Autologous Stem Cell Transplantation (ASCT) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) in the Determination Phase 3 Trial
    Hassoun, Hani
    Jacobus, Susanna J.
    Richardson, Paul G.
    Zonder, Jeffrey A.
    Voorhees, Peter M.
    Kaufman, Jonathan L.
    Yee, Andrew J.
    Scott, Emma C.
    Torka, Pallawi
    Libby, Edward
    Reeves, Brandi
    Wang, Michael L.
    Anderson, Larry D., Jr.
    Milner, Carter
    Gasparetto, Cristina J.
    Agha, Mounzer
    Khan, Abdullah
    Hurd, David Duane
    Avigan, David
    Costello, Caitlin
    Jakubowiak, Andrzej
    Lonial, Sagar
    Raje, Noopur
    Medvedova, Eva
    McCarthy, Philip L.
    Orlowski, Robert Z.
    Nadeem, Omar
    Laubach, Jacob P.
    Pasquini, Marcelo C.
    Giralt, Sergio A.
    Masone, Kelly
    Samur, Mehmet K.
    Perrot, Aurore
    Moreau, Philippe
    Avet-Loiseau, Herve
    Weller, Edie A.
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2022, 140 : 4834 - 4838
1